NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
Operating Income ContractionContracting
Percentile Rank87
3Y CAGR+6.9%
5Y CAGR+14.3%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+6.9%/yr
vs +8.4%/yr prior
5Y CAGR
+14.3%/yr
Recent deceleration
Acceleration
-1.6pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $18.20B | -39.3% |
| 2025 | $30.00B | +15.6% |
| 2024 | $25.96B | +74.1% |
| 2023 | $14.92B | +115.2% |
| 2022 | $6.93B | -25.6% |
| 2021 | $9.31B | +6.1% |
| 2020 | $8.77B | -18.7% |
| 2019 | $10.79B | -14.7% |
| 2018 | $12.65B | +22.9% |
| 2017 | $10.29B | - |